Richard Schwab
Overview
Explore the profile of Richard Schwab including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
2831
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vidigal T, Haddad F, Guimaraes T, Silva L, Andersen M, Schwab R, et al.
Sleep
. 2023 Dec;
47(3).
PMID: 38038363
Study Objectives: This study aimed to evaluate and compare measurements of standardized craniofacial and intraoral photographs between clinical and general population samples, between groups of individuals with an apnea-hypopnea index...
2.
Rajeev S, Roberts C, Brown E, Sprung V, Harrold J, Halford J, et al.
Diabetes Obes Metab
. 2023 Sep;
25(12):3621-3631.
PMID: 37667658
Aim: This study assessed the impact of dapagliflozin on food intake, eating behaviour, energy expenditure, magnetic resonance imaging (MRI)-determined brain response to food cues and body composition in patients with...
3.
4.
Rugo H, Cortes J, Barrios C, Cabrera P, Xu B, Huang C, et al.
Future Oncol
. 2022 Oct;
PMID: 36268941
Triple-negative breast cancer (TNBC) has the highest rate of distant metastasis and poorest overall survival among breast cancer subtypes. In a phase II study, adagloxad simolenin (AdaSim), a synthetic Globo...
5.
Remenar E, Doczi R, Dirner A, Sipos A, Perjesi A, Tihanyi D, et al.
JCO Precis Oncol
. 2022 Jan;
6:e2100344.
PMID: 35005996
No abstract available.
6.
Charo L, Eskander R, Sicklick J, Kim K, Lim H, Okamura R, et al.
JCO Precis Oncol
. 2022 Jan;
6:e2000508.
PMID: 35005995
Purpose: Next-generation sequencing is increasingly used in gynecologic and breast cancers. Multidisciplinary Molecular Tumor Board (MTB) may guide matched therapy; however, outcome data are limited. We evaluate the effect of...
7.
Laharnar N, Herberger S, Prochnow L, Chen N, Cistulli P, Pack A, et al.
Nat Sci Sleep
. 2021 Nov;
13:2039-2049.
PMID: 34785967
Purpose: An early prescreening in suspected obstructive sleep apnea (OSA) patients is desirable to expedite diagnosis and treatment. However, the accuracy and applicability of current prescreening tools is insufficient. We...
8.
Holfinger S, Lyons M, Keenan B, Mazzotti D, Mindel J, Maislin G, et al.
Chest
. 2021 Oct;
161(3):807-817.
PMID: 34717928
Background: Prediction tools without patient-reported symptoms could facilitate widespread identification of OSA. Research Question: What is the diagnostic performance of OSA prediction tools derived from machine learning using readily available...
9.
Szkukalek J, Doczi R, Dirner A, Boldizsar A, Varga A, Deri J, et al.
Diagnostics (Basel)
. 2021 Oct;
11(10).
PMID: 34679548
Background: We present the case of a 50-year-old female whose metastatic pancreatic neuroendocrine tumor (pNET) diagnosis was delayed by the COVID-19 pandemic. The patient was in critical condition at the...
10.
Weaver T, Pepin J, Schwab R, Shapiro C, Hedner J, Ahmed M, et al.
J Clin Sleep Med
. 2021 Oct;
17(10):1995-2007.
PMID: 34606437
Study Objectives: Solriamfetol, a dopamine/norepinephrine reuptake inhibitor, is approved in the United States and European Union for excessive daytime sleepiness in adults with narcolepsy (75-150 mg/day) or obstructive sleep apnea...